DAYANA GARZA: Open Payments
NPI 1669965083 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 12 payments from 8 companies in 2025. Trend: 2023 $123 · 2024 $232 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $98 |
| Merck Sharp & Dohme LLC | 2 | $68 |
| Incyte Corporation | 2 | $59 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $32 |
| SOBI, INC | 1 | $29 |
| Astellas Pharma US Inc | 1 | $29 |
| ABBVIE INC. | 1 | $24 |
Products named: LIVTENCITY, NIKTIMVO, PREVYMIS, DARZALEX, Vonjo, Cresemba, BOTOX.
Industry payments across TX — which companies pay providers there.
